Top Story

Metformin superior to myoinositol for metabolic parameters in PCOS

January 18, 2017

Women with polycystic ovary syndrome and overweight or obesity experienced greater improvements in hormonal, clinical and metabolic parameters after 6 months of treatment with metformin compared with myoinositol treatment, researchers recently reported.

Valentina Immediata, MD, of the department of obstetrics and gynecology, Università Cattolica del Sacro Cuore in Italy, and colleagues evaluated 34 women (mean age, 25.62 years; BMI, 32.55 kg/m2) with PCOS randomly assigned to 6 months of metformin (80 mg twice per day) or myoinositol (1,000 mg twice per day) to determine the effects of each on hormonal, clinical and metabolic parameters. After a 3-month washout period, participants were switched to the other treatment method for 6 months.

In the Journals Plus

Sequential therapy with rituximab effective for CD20–positive posttransplant lymphoproliferative disorder

January 18, 2017
Rituximab plus CHOP consolidation was safe and effective in patients with CD20–positive posttransplant lymphoproliferative disorder, according to results of a…
Meeting NewsPerspective

Survey: Physicians would like more goal-oriented communication with patients

January 18, 2017
WASHINGTON — According to survey results presented at the American College of Rheumatology Annual Meeting, 68% of physicians reported they would like more…
In the Journals

Thrombolysis treatment within 1 hour linked to best outcomes for acute ischemic stroke

January 18, 2017
Treatment with tissue plasminogen activator in the first 60 minutes after onset is associated with optimal outcomes for patients with acute ischemic stroke, according to…

Senate committee hearing on Price’s HHS nomination focuses on health policy, potential conflicts of interest

January 18, 2017
The U.S. Senate Committee on Health, Education, Labor and Pensions held a hearing today on the nomination of Tom Price, MD, (R-Ga.) as secretary of HHS that focused on…
More News Headlines »

Best of Retina Forum® 2016 - Diabetic Retinopathy: A Revolution in Treatment Options

This activity is supported by educational grants from Carl Zeiss Meditec, Inc. and Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) is an insidious, progressive disease. Diabetic macular edema (DME), which can occur at any…
More »
Original Article

Rate of Strabismus Detection on Digital Photographs Increases by Using Off-center Near Target

Journal of Pediatric Ophthalmology and Strabismus
Online Advanced Release, January 17, 2017
To increase the detection rate of strabismus on digital photographs, with the ultimate aim of developing a new…
More »
Meeting News

VIDEO: Farid gives pearls for secondary IOL implantation

January 17, 2017
More »